DYNAMICS OF THE POST-INFARCTION HEART REMODELING ON THE DATA OF ECHOCARDIOSCOPY IN THE APPLICATION OF RAMIPRIL AND ZOFENOPRIL
DOI:
https://doi.org/10.11603/1681-2786.2018.3.9754Keywords:
myocardial infarction, post-infarction cardiac remodeling, arterial pressure, Ramipril, ZofenoprilAbstract
Purpose: to evaluate the dynamics of post-infarction cardiac remodeling using the method of echocardioscopy in patients with myocardial infarction in the acute period, after 14 days of acute coronary event, and in the isolated period – 3 months later, with the use of drugs for the group of angiotensin converting enzyme inhibitors, Ramipril and Zofenopril.
Materials and Methods. We examined 54 patients, who were diagnosed with acute myocardial infarction at the time of hospitalization. We evaluated and compared heart size by the results of echocardiography, blood pressure, heart rate, and dual-dose magnitude.
Results and Discussion. The inclusion of Ramipril and Zofenopril in the complex therapy of patients with AMI is accompanied by almost the same effect on reducing blood pressure and its stable content within the physiological norm within three months of the post-infarction period. The use of Zofenopril in comparison with Ramipril in patients come through AMI after 3 months is accompanied by a significant decrease in heart rate, rate pressure product, end-systolic volume (by 18.7 %), an increase in the ejection fraction (by 16.8 %), which indicates a positive effect of the drug only on the value of blood pressure, but also on the state of the myocardium and its recovery in the post-infarction period.
Conclusions. Inclusion in the complex therapy of patients with acute myocardial infarction of Ramipril and Zofenopril creates prerequisites for reducing the severity of myocardial damage and its recovery in the post-infarction period.
References
Smetanin, A.V., Yevdokimov, V.V., Komissarova, T.A., & Churkina, N.V. (2012). Vliyaniye zofenoprila na pokazateli tsentralnoy gemodinamiki i remodelirovaniye levogo zheludochka u bolnykh IBS i AG [Effect of zofenopril on central hemodynamic parameters and left ventricular remodeling in patients with coronary artery disease and hypertension]. Materialy Vserossiyskogo nauchno-obrazovatelnogo foruma. Kardiologiya – Materials of the All-Russian Scientific and Educational Forum. Cardiology. Moscow [in Russian].
Gensh, N. (2015). Optimalnaya terapiya ostrogo infarkta miokarda: mesto i rol ingibitorov APF [Optimal therapy of acute myocardial infarction: the place and role of ACE inhibitors]. Retrieved from: http://www.webcardio.org.
Hura, E.Yu. (2014). Osoblyvosti zmin dobovoho monitoruvannia arterialnoho tysku ta yoho variabelnist u patsiientiv iz hipertonichnoiu khvoroboiu v poiednanni z tsukrovym diabetom 2-ho typu [Features of changes in daily blood pressure monitoring and its variability in patients with hypertension in combination with type 2 diabetes mellitus]. Mizhnarodnyi endokrynolohichnyi zhurnal – International Endocrinology Journal, 6 (62) [in Ukrainian].
Drapkina, O.M. (2011). Ingibitory angtotenzinprevrashchayushchego fermenta v lechenii patsiyentov s ishemicheskoy boleznyu serdtsa [Inhibitors of angtotensin-converting enzyme in the treatment of patients with coronary heart disease]. Arterialnaya gipertenziya – Hypertension, 17, 1, 79-82 [in Russian].
Yevdokimova, A.G., Radzevich, A.E., Kovalenko, Ye.V., Yevdokimov, V.V., & Smetanin, A.V. (2012). Antianginalnyye i antiishemicheskiye effekty zofenoprila u bolnykh IBS i AG [Antianginal and anti-ischemic effects of zofenopril in patients with CHD and AH.]. Materialy Vserossiyskogo nauchno-obrazovatelnogo foruma “Kardiologiya 2012” – Materials of the All-Russian Scientific and Educational Forum Cardiology. Moscow: MGMSU [in Russian].
(2008). ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. Eur. Heart J., 92, 2389-2442.
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish in this journal agree to the following terms:
1. The authors reserve the right to authorship of the work and pass the journal right of first publication of this work is licensed under a Creative Commons Attribution License, which allows others to freely distribute the work published with reference to the authors of the original work and the first publication of this magazine.
2. Authors are entitled to enter into a separate agreement on additional non-exclusive distribution of work in the form in which it was published in the magazine (eg work place in the electronic repository institution or publish monographs in part), provided that the reference to the first publication of this magazine.
3. Policy magazine allows and encourages authors placement on the Internet (eg, in storage facilities or on personal websites) manuscript of how to submit the manuscript to the editor and during his editorial processing, since it contributes to productive scientific discussion and positive impact on the efficiency and dynamics of citing published work (see. The Effect of Open Access).